|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. DALY disability-adjusted life-year DCIS ductal carcinoma in situ DES diethylstilbestrol DIRAC Directory of Radiotherapy Centres DTP diphtheria, tetanus, polio DVI direct visual inspection EC epirubicin and cyclophosphamide ED Europa Donna ER estrogen receptor ESMO European Society for Medical Oncology FAC 5-fluorouracil, doxorubicin, and cyclophosphamide FCTC Framework Convention on Tobacco Control FDA Food and Drug Administration GAVI Global Alliance for Vaccines and Immunization GNI gross national income GSK GlaxoSmithKline HBsAg hepatitis B surface antigen HBV hepatitis B virus HC hybrid capture HCC hepatocellular carcinoma HCV hepatitis C virus HER-2/neu Human epidermal growth factor receptor HKL Hospital Kuala Lumpur HINARI Health InterNetwork Access to Research Initiative HIV/AIDS human immunodeficiency virus/acquired immunodeficiency syndrome HPV human papillomavirus HSIL high-grade squamous intraepithelial lesion HTLV-1 human T lymphotropic virus type 1 IAEA International Atomic Energy Agency IARC International Agency for Research on Cancer IHC immunohistochemistry ILO International Labor Organization INCB International Narcotics Control Board INCTR International Network for Cancer Treatment and Research INEN Instituto Nacional de Enfermedades Neoplásicas (National Institute for Neoplastic Illnesses; Lima, Peru) IOM Institute of Medicine
|
|
|||||||||||||||
